Eric L. Dobmeier
2014
In 2014, Eric L. Dobmeier earned a total compensation of $2.4M as Chief Operating Officer at Seattle Genetics, a 2% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $260,480 |
---|---|
Option Awards | $841,046 |
Salary | $472,262 |
Stock Awards | $793,620 |
Other | $8,280 |
Total | $2,375,688 |
Dobmeier received $841K in option awards, accounting for 35% of the total pay in 2014.
Dobmeier also received $260.5K in non-equity incentive plan, $472.3K in salary, $793.6K in stock awards and $8.3K in other compensation.
Rankings
In 2014, Eric L. Dobmeier's compensation ranked 3,855th out of 13,032 executives tracked by ExecPay. In other words, Dobmeier earned more than 70.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,855 out of 13,032 | 70th |
Division Manufacturing | 1,363 out of 4,966 | 73rd |
Major group Chemicals And Allied Products | 440 out of 1,686 | 74th |
Industry group Drugs | 340 out of 1,365 | 75th |
Industry Biological Products, Except Diagnostic Substances | 56 out of 236 | 76th |
Source: SEC filing on April 5, 2017.
Dobmeier's colleagues
We found five more compensation records of executives who worked with Eric L. Dobmeier at Seattle Genetics in 2014.
2014
Clay Siegall
Seattle Genetics
Chief Executive Officer
2014
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2014
Christopher Boerner
Seattle Genetics
Former EVP, Commercial
2014
Todd Simpson
Seattle Genetics
Chief Financial Officer
2014
Vaughn Himes
Seattle Genetics